offer, page-7

I have always believed the psoriasis treatment is small fry.
From my limited searches on the internet and other biotechs I have not seen such a positive result for lung cancer treatment such as Arana have their hands on and I believe that is a big reason why Cephalon are interested in Arana. I know it's a long way from development (possibly 2012ish before commercialisation)to a treatment yet, but at these low prices definitely a risk worth taking for Cephalon and get their hands on the superhumanisation of antibodies technology as well which has obviously been working for the clients Arana already have. Very sad to see this leave the country at any price.